ARANZ Medical receives Global ICT Excellence Award from WITSA
Image Caption: Dr Bruce Davey, CEO of ARANZ Medical with a key innovation: Silhouette, an FDA-approved advanced wound surveillance
system
CHRISTCHURCH, New Zealand and BRASILIA, Brasil, October 5, 2016 – ARANZ Medical, a specialist in 3D scanning and informatics solutions for the healthcare sector, has been named the Private Sector
Excellence Award winner at the World Information Technology and Services Alliance (WITSA) Global ICT Excellence Awards
2016. The award was presented by WITSA, the recognized leading voice of the global ICT industry, at the World Congress
Gala Dinner in Brasilia last night, part of the 2016 World Congress on Information Technology (WCIT).
ARANZ Medical’s key innovations transform a number of crucial clinical assessment practices, improve quality of care,
and make delivery of care more cost-effective. The innovations include: Silhouette, an FDA-approved advanced wound
surveillance system; and FastSCAN which enables the custom-fit of orthotics and prosthetics.
Dr Bruce Davey, CEO of ARANZ Medical says, “We’re very proud to have our achievement in using ICT to transform
healthcare and impact peoples’ lives recognised in this way. We have an incredibly talented and dedicated team who live
and breathe our mission to help people heal people. We do this by developing highly sophisticated, yet easy to use
technology that transforms some of the most primitive processes in healthcare.”
WITSA Chairman Santiago Gutierrez was impressed by the candidates from around the world for the 2016 WITSA Global ICT
Excellence Awards and congratulated ARANZ Medical CEO Bruce Davey for the company being the top pick in the Private
Sector IT Excellence category.
The WITSA Global ICT Excellence Award Ceremony is held once every two years in conjunction with the World Congress on
Information Technology to recognize select organizations whose use of IT has exhibited exceptional achievement in using
ICT to benefit societies, governments, organizations and individuals.
ARANZ Medical’s solutions are making a difference in over 35 countries across the globe in a range of clinical practice
and research settings: from Africa, where the World Health Organization is using Silhouette in rural Africa as part of
an important study of Buruli ulcer, one of the world’s most neglected tropical diseases; to some of the biggest
healthcare providers in the United States and United Kingdom.
Dr Davey says, “Our technology equips researchers and clinicians with important new knowledge which empowers them to
improve the lives of millions of people worldwide, including high risk groups such as diabetes sufferers and the
elderly.”
Demand for ARANZ Medical’s solutions is growing rapidly due to the increased prevalence of diseases like diabetes, an
ageing population, more accountable healthcare and the emerging telehealth trend.
Over 40 million people around the world suffer from chronic wounds such as pressure ulcers, venous ulcers and diabetic
ulcers and this number is expected to grow to more than 60 million by 2017. Wounds can lead to significant pain, sepsis,
re-admissions, social isolation, amputations, and death. Amputation rates are also increasing, with some experts
estimating that every 30 seconds a lower limb is lost to diabetes somewhere in the world.
WITSA award categories include: Private Sector Excellence, Public Sector Excellence, Mobile Excellence, Digital
Opportunity and Sustainable Growth. In addition, a special Chairman’s Award is presented to a nominee from the entire
pool of candidates from all five categories.
Nominations for the awards are made by WITSA’s member organisations from over 80 countries who represent more than 90
percent of the world ICT market. ARANZ Medical was nominated for the Private Sector Excellence Award by NZTech.
Dr Davey says, “We’d also like to acknowledge the work of WITSA as well as the outstanding support we’ve received from
key organisations including New Zealand Trade & Enterprise, Callaghan Innovation and NZTech as we’ve worked to become a recognised global ICT innovator in the
healthcare industry.”
ENDS
About ARANZ Medical
ARANZ Medical Ltd is an innovator of medical solutions, specializing in 3D scanning applications that transform clinical
processes in wound care and orthotics/ prosthetics. Key innovations include Silhouette, an FDA-approved advanced wound
surveillance system which supports better wound care management and increases productivity in clinical practice, and
FastSCAN 3D scanning systems for orthoses and prosthetics and other medical applications. ARANZ Medical has a global
customer base spanning the United States, United Kingdom, Australia, Canada, Europe, Asia, and New Zealand. For more
information visitwww.aranzmedical.com/